Higher DI‐GM scores were consistently linked with reduced systemic and intestinal inflammation, as evidenced by lower levels of CRP, TMAO, LPS, CEA, and calprotectin lower across quartiles. The gene discussed is CEACAM5; the disease is inflammation.